Ali Gholamrezanezhad1, Kyle Basques2, Ali Batouli3, George Matcuk1, Abass Alavi4, Hossein Jadvar5. 1. 1 Department of Radiology, Division of Musculoskeletal Imaging, Keck School of Medicine, University of Southern California, 1520 San Pablo St, Los Angeles, CA 90033. 2. 2 Department of Radiology, Division of Musculoskeletal Imaging, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH. 3. 3 Department of Radiology, Allegheny General Hospital, Pittsburgh, PA. 4. 4 Department of Radiology, Division of Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA. 5. 5 Department of Radiology, Division of Nuclear Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Abstract
OBJECTIVE: With improvements in PET/CT and PET/MRI over the last decade, as well as increased understanding of the pathophysiology of musculoskeletal diseases, there is an emerging potential for PET as a primary or complementary modality in the management of rheumatologic and orthopedic conditions. CONCLUSION: We discuss the role of PET/CT and PET/MRI in nononcologic musculoskeletal disorders, including inflammatory and infectious conditions and postoperative complications. There is great potential for an increased role for PET to serve as a primary or complementary modality in the management of orthopedic and rheumatologic disorders.
OBJECTIVE: With improvements in PET/CT and PET/MRI over the last decade, as well as increased understanding of the pathophysiology of musculoskeletal diseases, there is an emerging potential for PET as a primary or complementary modality in the management of rheumatologic and orthopedic conditions. CONCLUSION: We discuss the role of PET/CT and PET/MRI in nononcologic musculoskeletal disorders, including inflammatory and infectious conditions and postoperative complications. There is great potential for an increased role for PET to serve as a primary or complementary modality in the management of orthopedic and rheumatologic disorders.
Authors: Benedicte Vanquickenborne; Alex Maes; Johan Nuyts; Frank Van Acker; Jos Stuyck; Michiel Mulier; Alfons Verbruggen; Luc Mortelmans Journal: Eur J Nucl Med Mol Imaging Date: 2003-03-04 Impact factor: 9.236
Authors: Ole L Nielsen; Pia Afzelius; Dirk Bender; Henrik C Schønheyder; Páll S Leifsson; Karin M Nielsen; Jytte O Larsen; Svend B Jensen; Aage Ko Alstrup Journal: Am J Nucl Med Mol Imaging Date: 2015-01-15
Authors: Michelle L Frost; Gary J R Cook; Glen M Blake; Paul K Marsden; Nigel A Benatar; Ignac Fogelman Journal: J Bone Miner Res Date: 2003-12 Impact factor: 6.741
Authors: Anne Roivainen; Riitta Parkkola; Timo Yli-Kerttula; Pertti Lehikoinen; Tapio Viljanen; Timo Möttönen; Pirjo Nuutila; Heikki Minn Journal: Arthritis Rheum Date: 2003-11
Authors: Abhijit J Chaudhari; William Y Raynor; Ali Gholamrezanezhad; Thomas J Werner; Chamith S Rajapakse; Abass Alavi Journal: PET Clin Date: 2021-01
Authors: Christian Philipp Reinert; Christina Pfannenberg; Helmut Dittmann; Brigitte Gückel; Christian la Fougère; Konstantin Nikolaou; Sebastian Hoefert Journal: J Clin Med Date: 2022-07-10 Impact factor: 4.964